Peripheral Pulmonary Lesions

2

Review clinical trials related to Peripheral Pulmonary Lesions. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Utility of Needle-Based Confocal Laser Endomicroscopy for Peripheral Pulmonary Lesions

This prospective, multicenter diagnostic accuracy study will evaluate the clinical utility of needle-based confocal laser endomicroscopy (nCLE) for differentiating malignant from benign peripheral pulmonary lesions (PPLs). A total of 100 participants undergoing bronchoscopic evaluation of PPLs will be enrolled at three hospitals in China. Following successful lesion localization using radial endobronchial ultrasound, nCLE imaging will be performed after intravenous administration of fluorescein, followed by standard bronchoscopic tissue sampling. nCLE findings will be compared with the final diagnosis established by histopathology, surgical pathology, or six-month clinical and imaging follow-up when necessary. The primary outcomes are the sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy of nCLE. Procedure duration and procedure-related adverse events will also be recorded. The investigators hypothesize that nCLE can accurately distinguish malignant from benign PPLs in real time.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: First Affiliated Hospital of Ningbo UniversityUpdated: Sep 21, 2026Locations: 3Duration: 6 Months
Eligibility criteria

Age 18 years or older. [+4]

A contraindication to bronchoscopy, including severe cardiopulmonary disease,coa... [+6]

Status: Not yet recruiting

Optical Biopsy for Peripheral Pulmonary Lesions

The purpose of the study is to describe confocal laser endomicroscopy (CLE) interpretation criteria for different types of peripheral pulmonary lesions (PPLs), with histopathological correlation, and to perform the validation of these criteria.

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Shanghai Chest HospitalUpdated: Jun 14, 2024Locations: 1
Eligibility criteria

Patients older than 18 years. [+2]

Patients with known allergy for fluorescein. [+3]